Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
A well-tolerated rAAV vector-mediated gene therapy in normotensive Brown Norway rats is used to reduce intraocular pressure in a dose dependent manner, encouraging further evaluations on pre-clinical models of glaucoma.
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-11-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-022-04134-w |